Skip to content
TrialScanner

NCT04502888

Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin

Phase 1TerminatedSTTKLead

Registry record

Lead sponsor
Shattuck Labs, Inc.
Conditions
Cutaneous Squamous Cell Carcinoma; Squamous Cell Carcinoma of Head and Neck
Primary completion
Apr 8, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04502888 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04502888: Ph1 Study of SL-172154... | TrialScanner